Antiretroviral Therapy May Reduce Bone Mineral Density in Adolescents and Elderly With HIV
Particular antiretroviral therapy (ART) regimens may decrease bone mass density (BMD) in both adolescents and older people living with HIV (PWHIV).
Pediatric Rheumatology
Consultation Wait Time Benchmarks Met, But Delays Seen for Older Children With JIA
Researchers assessed wait times at a single center for patients with juvenile idiopathic arthritis and described factors associated with longer wait times.
Proton Pump Inhibitors May Increase Fracture Risk in Children
PPI use in children is associated with a small but significant increased risk for any fracture.
Juvenile Dermatomyositis Associated With Risk for Delayed Pubertal Development
Researchers studied growth and puberty in a multinational prospective cohort of children with juvenile dermatomyositis.
Gene Polymorphisms in JIA-Associated Uveitis Not Linked to Idiopathic Pediatric Uveitis
Researchers addressed the genetic association between juvenile idiopathic arthritis-associated uveitis and idiopathic pediatric uveitis.
Abatacept Maintains Effective Diphtheria/Tetanus Vaccination Protection in Polyarticular-Course JIA
Researchers assessed protective antibody responses to diphtheria and tetanus vaccination in patients with polyarticular-course juvenile idiopathic arthritis.
Drug Reaction With Eosinophilia and Systemic Symptoms Linked to High Fatality Lung Disease in JIA
Drug reaction with eosinophilia and systemic symptoms (DReSS) with exposure to interleukin-1 or interleukin-6 inhibition may be linked to high fatality lung disease in systemic juvenile idiopathic arthritis.
Identification of a Protein Epitope Targeted by the Kawasaki Disease Antibody Response
A protein epitope targeted by the antibody response in children with Kawasaki disease has been identified.
Consensus Recommendations for the Diagnosis and Treatment of Secondary Osteoporosis in Children
The Osteogenesis Imperfecta and Childhood Osteoporosis Working Group of the Spanish Society of Pediatric Rheumatology developed guidelines for the prevention, diagnosis, and treatment of secondary childhood osteoporosis.
Live Attenuated Booster Vaccines Are Safe for Children With Rheumatic Disease on Immunosuppressive Therapy
Researchers collected retrospective data from patients with rheumatic diseases who received live attenuated booster doses of measles-mumps-rubella or measles-mumps-rubella varicella during treatment with immunosuppressive therapy.
Next post in Pediatric Rheumatology
